Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million

Go back to Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million
(NYSE: BHVN) Delayed: 14.72 --0 (-0%)
Previous Close $14.72    52 Week High
Open $14.72    52 Week Low
Day High $14.72    P/E N/A 
Day Low $14.72    EPS
Volume 617       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 60.59 --0 (-0%)
Previous Close $60.59    52 Week High $3.48 
Open $60.59    52 Week Low $0.80 
Day High $60.59    P/E N/A 
Day Low $60.59    EPS $-1.54 
Volume 5,452